MX342323B - Composicion solida para la administracion oral de tintes y uso de diagnostico de la misma. - Google Patents

Composicion solida para la administracion oral de tintes y uso de diagnostico de la misma.

Info

Publication number
MX342323B
MX342323B MX2012010125A MX2012010125A MX342323B MX 342323 B MX342323 B MX 342323B MX 2012010125 A MX2012010125 A MX 2012010125A MX 2012010125 A MX2012010125 A MX 2012010125A MX 342323 B MX342323 B MX 342323B
Authority
MX
Mexico
Prior art keywords
dyes
oral administration
diagnostic use
solid composition
diagnostic
Prior art date
Application number
MX2012010125A
Other languages
English (en)
Other versions
MX2012010125A (es
Inventor
Celasco Giuseppe
Moro Luigi
Severino Ajani Mauro
Villa Roberto
Repici Alessandro
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of MX2012010125A publication Critical patent/MX2012010125A/es
Publication of MX342323B publication Critical patent/MX342323B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente se describen las composiciones sólidas para la administración oral de tintes, y el uso de diagnóstico de las mismas. Preferiblemente, tal uso de diagnóstico se dirige a la evaluación de diagnóstico del tracto gastrointestinal.
MX2012010125A 2010-03-04 2011-03-02 Composicion solida para la administracion oral de tintes y uso de diagnostico de la misma. MX342323B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A000345A IT1398643B1 (it) 2010-03-04 2010-03-04 Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
US32755710P 2010-04-23 2010-04-23
PCT/IB2011/050881 WO2011107945A1 (en) 2010-03-04 2011-03-02 Solid composition for the oral administration of dyes and diagnostic use thereof

Publications (2)

Publication Number Publication Date
MX2012010125A MX2012010125A (es) 2013-02-26
MX342323B true MX342323B (es) 2016-09-23

Family

ID=42647312

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012010125A MX342323B (es) 2010-03-04 2011-03-02 Composicion solida para la administracion oral de tintes y uso de diagnostico de la misma.

Country Status (26)

Country Link
US (6) US8545811B2 (es)
EP (2) EP2542268B1 (es)
JP (1) JP5770752B2 (es)
KR (1) KR101763700B1 (es)
CN (1) CN102811747B (es)
AU (1) AU2011222496B2 (es)
BR (1) BR112012022373B1 (es)
CA (1) CA2790143C (es)
CY (1) CY1123967T1 (es)
DK (2) DK3011975T3 (es)
ES (2) ES2602157T3 (es)
FR (1) FR21C1009I1 (es)
HR (2) HRP20161366T1 (es)
HU (3) HUE053977T2 (es)
IL (1) IL221541A (es)
IT (1) IT1398643B1 (es)
LT (2) LT2542268T (es)
MX (1) MX342323B (es)
NZ (1) NZ602130A (es)
PL (2) PL3011975T3 (es)
PT (2) PT3011975T (es)
RS (2) RS55414B1 (es)
RU (1) RU2561034C2 (es)
SI (1) SI3011975T1 (es)
WO (1) WO2011107945A1 (es)
ZA (1) ZA201206360B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
ATE251449T1 (de) 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis
US10925978B2 (en) * 2014-01-29 2021-02-23 Cosmo Technologies Limited Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum
US10124074B2 (en) * 2014-02-26 2018-11-13 Toufic Kachaamy Indirect chromoendoscopy with an oral indigo carmine base preparation
US10052398B2 (en) 2014-12-08 2018-08-21 Kinnos Inc. Additive compositions for pigmented disinfection and methods thereof
US20180116849A1 (en) * 2015-04-23 2018-05-03 Obalon Therapeutics, Inc. Systems and methods for determining failure of intragastric devices
CN108603142B (zh) 2016-02-12 2021-12-31 金诺斯公司 用于表面净化的组合物和方法
CA3021518A1 (en) 2016-04-19 2017-10-26 Conaris Research Institute Ag Shellac microcapsule formulations and compositions
CA3031522A1 (en) 2016-07-25 2018-02-01 Kinnos Inc. Device and related compositions and methods for use in surface decontamination
US20200061212A1 (en) 2016-11-28 2020-02-27 Cosmo Technologies Ltd. Solid oral composition containing dyes
FR3059664B1 (fr) 2016-12-01 2019-01-25 Provepharm Life Solutions Procede de preparation du carmin d’indigo
US11464371B2 (en) 2018-07-12 2022-10-11 Kinnos Inc. Devices, compositions, and methods for use in surface decontamination
CN108888765B (zh) * 2018-07-16 2021-02-26 山东理工大学 一种释放亚甲基蓝聚集体的含亚甲基蓝的二氧化硅/虫胶复合颗粒的制备方法
CN111184876B (zh) * 2020-02-20 2022-03-04 沈伟 一种消化道黏膜染色剂、制备方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
CA2097695C (en) * 1991-10-31 2000-08-08 Mark J. Malmros Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
ATE251449T1 (de) 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US6584630B1 (en) 2000-04-06 2003-07-01 Ohio Medical Instrument Company, Inc. Radiolucent surgical table extension assembly and method
WO2001076478A1 (en) 2000-04-10 2001-10-18 Nordisk Terapi As System for testing and exercising sensorimotoric control of the neck
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
US7217410B2 (en) 2003-06-17 2007-05-15 The Board Of Trustees Of The Universtiy Of Illinois Surface modified protein microparticles
WO2007056439A1 (en) * 2005-11-08 2007-05-18 Collegium Pharmaceutical, Inc. Salts of methylene blue and its derivatives
FR2894253B1 (fr) * 2005-12-06 2009-11-13 Pentax Corp Composition d'histocolorant pour endoscope

Also Published As

Publication number Publication date
US20130058867A1 (en) 2013-03-07
CN102811747A (zh) 2012-12-05
CA2790143A1 (en) 2011-09-09
CY1123967T1 (el) 2022-05-27
RS61641B1 (sr) 2021-04-29
SI3011975T1 (sl) 2021-05-31
ZA201206360B (en) 2013-10-30
JP5770752B2 (ja) 2015-08-26
US10265420B2 (en) 2019-04-23
US20160184460A1 (en) 2016-06-30
EP2542268B1 (en) 2016-08-10
US20200268909A1 (en) 2020-08-27
IT1398643B1 (it) 2013-03-08
RS55414B1 (sr) 2017-04-28
DK2542268T3 (en) 2016-11-28
HUS2100005I1 (hu) 2021-03-29
RU2012142192A (ru) 2014-04-10
KR20130015008A (ko) 2013-02-12
US20130295013A1 (en) 2013-11-07
BR112012022373A2 (pt) 2019-11-26
KR101763700B1 (ko) 2017-08-01
PL2542268T3 (pl) 2017-05-31
ITMI20100345A1 (it) 2011-09-05
AU2011222496A2 (en) 2012-09-20
NZ602130A (en) 2014-07-25
PL3011975T3 (pl) 2021-06-28
JP2013521271A (ja) 2013-06-10
IL221541A (en) 2016-03-31
DK3011975T3 (da) 2021-03-29
EP3011975B1 (en) 2021-01-20
WO2011107945A1 (en) 2011-09-09
HUE030246T2 (en) 2017-04-28
LT2542268T (lt) 2016-12-12
AU2011222496B2 (en) 2016-08-18
LT3011975T (lt) 2021-04-26
ES2602157T3 (es) 2017-02-17
HRP20161366T1 (hr) 2017-02-24
MX2012010125A (es) 2013-02-26
US8545811B2 (en) 2013-10-01
EP2542268A1 (en) 2013-01-09
CN102811747B (zh) 2016-02-24
PT2542268T (pt) 2016-11-14
US9402923B2 (en) 2016-08-02
ES2863986T3 (es) 2021-10-13
FR21C1009I1 (fr) 2021-05-07
CA2790143C (en) 2019-01-22
EP3011975A1 (en) 2016-04-27
AU2011222496A1 (en) 2012-09-20
PT3011975T (pt) 2021-03-19
HUE053977T2 (hu) 2021-07-28
US20130287690A1 (en) 2013-10-31
US9402922B2 (en) 2016-08-02
HRP20210493T1 (hr) 2021-05-14
RU2561034C2 (ru) 2015-08-20
BR112012022373B1 (pt) 2021-12-14
US20180214580A1 (en) 2018-08-02

Similar Documents

Publication Publication Date Title
MX342323B (es) Composicion solida para la administracion oral de tintes y uso de diagnostico de la misma.
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
WO2012047631A3 (en) Compositions and methods useful for the treatment and diagnosis of inflammatory bowel disease
MY162146A (en) Pharmaceutical composition
EP2371347A3 (en) Oral care compositions
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
WO2011086093A3 (en) Pharmaceutical compositions for oral administration of insulin peptides
WO2011106322A3 (en) Biomarkers for acute ischemic stroke
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
TR201903026T4 (tr) S100a4 anti̇korlari ve bunlarin terapöti̇k kullanimlari.
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
MX2013007233A (es) Composiciones para el cuidado oral fluidas.
EP2568810A4 (en) COMPOSITIONS OF DARUNAVIR
MX2015004935A (es) Composicion oral solida que contiene colorantes para uso en diagnostico endoscopico.
TR201109160A2 (tr) Eplerenon içeren yeni farmasötik kompozisyonlar.
WO2011153224A3 (en) Diagnostic methods and compositions for treatment of cancer
WO2010129505A3 (en) Napthylene inhibitors of cyclooxygenase
WO2011107922A3 (en) Extended release composition of milnacipran
WO2011002423A3 (en) Solubility enhancing pharmaceutical composition
WO2011002425A3 (en) Pharmaceutical composition increasing solubility and stability
UA59396U (ru) Применение композиций нестероидных противовоспалительных средств с кофеином как препаратов с антиэкссудативной активностью

Legal Events

Date Code Title Description
FG Grant or registration